» Articles » PMID: 23112547

MUC5AC/β-catenin Expression and KRAS Gene Alteration in Laterally Spreading Colorectal Tumors

Overview
Specialty Gastroenterology
Date 2012 Nov 1
PMID 23112547
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To clarify differences in mucin phenotype, proliferative activity and oncogenetic alteration among subtypes of colorectal laterally spreading tumor (LST).

Methods: LSTs, defined as superficial elevated lesions greater than 10 mm in diameter with a low vertical axis, were macroscopically classified into two subtypes: (1) a granular type (Gr-LST) composed of superficially spreading aggregates of nodules forming a flat-based lesion with a granulonodular and uneven surface; and (2) a non-granular type (NGr-LST) with a flat smooth surface and an absence of granulonodular formation. A total of 69 LSTs, comprising 36 Gr-LSTs and 33 NGr-LSTs, were immunohistochemically stained with MUC2, MUC5AC, MUC6, CD10 (markers of gastrointestinal cell lineage), p53, β-catenin and Ki-67 antibodies, and examined for alteration in exon 1 of v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) and exon 15 of v-raf murine sarcoma viral oncogene homologue B1 (BRAF) by polymerase chain reaction followed by direct sequencing.

Results: Histologically, 15 Gr-LST samples were adenomas with low-grade dysplasia (LGD), 12 were high-grade dysplasia (HGD) and 9 were adenocarcinomas invading the submucosa (INV), while 12 NGr-LSTs demonstrated LGD, 14 HGD and 7 INV. In the proximal colon, MUC5AC expression was significantly higher in the Gr-type than the NGr-type. MUC6 was expressed only in NGr-LST. MUC2 or CD10 did not differ. P53 expression demonstrated a significant stepwise increment in progression through LGD-HGD-INV with both types of LST. Nuclear β-catenin expression was significantly higher in the NGr-type. Ki-67 expression was significantly higher in the Gr-type in the lower one third zone of the tumor. In proximal, but not distal colon tumors, the incidence of KRAS provided mutation was significantly higher in the Gr-type harboring a specific mutational pattern (G12V). BRAF mutations (V600E) were detected only in two Gr-LSTs.

Conclusion: The two subtypes of LST, especially in the proximal colon, have differing phenotypes of gastrointestinal cell lineage, proliferation and activation of Wnt/β-catenin or RAS/RAF/extracellular signal-regulated kinase signaling.

Citing Articles

Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer.

Pothuraju R, Krishn S, Gautam S, Pai P, Ganguly K, Chaudhary S Cancers (Basel). 2020; 12(3).

PMID: 32168759 PMC: 7139953. DOI: 10.3390/cancers12030649.


Comparison of the histopathological characteristics of large colorectal laterally spreading tumors according to growth pattern.

Saito T, Kobayashi K, Sada M, Matsumoto Y, Mukae M, Kawagishi K J Anus Rectum Colon. 2019; 3(4):152-159.

PMID: 31768465 PMC: 6845292. DOI: 10.23922/jarc.2018-036.


[Expression of Wnt and integrin pathways in colorectal laterally spreading tumors and their correlation with endoscopic subtypes].

Wu J, Huo J, Wang D, Wang C, Lv L Nan Fang Yi Ke Da Xue Xue Bao. 2017; 37(9):1234-1241.

PMID: 28951368 PMC: 6765489.


Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer.

Lennerz J, van der Sloot K, Le L, Batten J, Han J, Fan K Int J Colorectal Dis. 2016; 31(5):973-982.

PMID: 27026089 DOI: 10.1007/s00384-016-2574-x.

References
1.
Bartman A, Sanderson S, Ewing S, Niehans G, Wiehr C, Evans M . Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer. 1999; 80(2):210-8. DOI: 10.1002/(sici)1097-0215(19990118)80:2<210::aid-ijc9>3.0.co;2-u. View

2.
Wong S, Lo E, Lee K, Chan J, Hsiao W . Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res. 2004; 10(4):1401-8. DOI: 10.1158/1078-0432.ccr-0157-03. View

3.
Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S . Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 2002; 295(5560):1726-9. DOI: 10.1126/science.1069094. View

4.
Ho S, Niehans G, Lyftogt C, Yan P, Cherwitz D, Gum E . Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res. 1993; 53(3):641-51. View

5.
Bu X, Li N, Tian X, Li L, Wang J, Yu X . Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. World J Gastroenterol. 2010; 16(32):4089-94. PMC: 2928465. DOI: 10.3748/wjg.v16.i32.4089. View